{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:07:39Z","timestamp":1788808059303,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012990","name":"Siena University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.resinv.2019.09.005","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T14:25:14Z","timestamp":1573223114000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Serum amyloid A: A potential biomarker of lung disorders"],"prefix":"10.1016","volume":"58","author":[{"given":"Lucia","family":"Vietri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Fui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bergantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriana","family":"d\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cameli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piersante","family":"Sestini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rottoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bargagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.resinv.2019.09.005_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1365-3083.1998.00394.x","article-title":"Human serum amyloid A has cytokine-like properties","volume":"48","author":"Patel","year":"1998","journal-title":"Scand J Immunol"},{"issue":"4","key":"10.1016\/j.resinv.2019.09.005_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1515\/CCLM.1999.063","article-title":"Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness","volume":"37","author":"Yamada","year":"1999","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.resinv.2019.09.005_bib3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI107642","article-title":"A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils","volume":"53","author":"Husby","year":"1974","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.resinv.2019.09.005_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-291X(05)80107-X","article-title":"The N-terminal segment of protein AA determines its fibrillogenic property","volume":"182","author":"Westermark","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 3","key":"10.1016\/j.resinv.2019.09.005_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/bj3340489","article-title":"Regulation of serum amyloid A protein expression during the acute-phase response","volume":"334","author":"Jensen","year":"1998","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.resinv.2019.09.005_bib6","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1021\/bi00405a044","article-title":"Amino acid structures of multiple forms of amyloid-related serum protein SAA from a single individual","volume":"27","author":"Dwulet","year":"1988","journal-title":"Biochemistry"},{"issue":"Pt 3","key":"10.1016\/j.resinv.2019.09.005_bib7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1042\/bj3181041","article-title":"Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis","volume":"318","author":"Patel","year":"1996","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.resinv.2019.09.005_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0021-9150(93)90155-N","article-title":"Serum amyloid A (SAA): an acute phase protein and apolipoprotein","volume":"102","author":"Malle","year":"1993","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.resinv.2019.09.005_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00062752-200001000-00012","article-title":"Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states","volume":"7","author":"Urieli-Shoval","year":"2000","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"10.1016\/j.resinv.2019.09.005_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(97)00196-1","article-title":"Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain","volume":"225","author":"Liang","year":"1997","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.resinv.2019.09.005_bib11","first-page":"785","article-title":"Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells","volume":"26","author":"Kumon","year":"1999","journal-title":"J Rheumatol"},{"issue":"Pt 2","key":"10.1016\/j.resinv.2019.09.005_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1042\/bj3220663","article-title":"Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2","volume":"322","author":"Kluve-Beckerman","year":"1997","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.resinv.2019.09.005_bib13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1084\/jem.148.4.1020","article-title":"Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes","volume":"148","author":"Lavie","year":"1978","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.resinv.2019.09.005_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-3083.1995.tb03538.x","article-title":"Cathepsin B generates the most common form of amyloid A (76 residues) as a degradation product from serum amyloid A","volume":"41","author":"Yamada","year":"1995","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.resinv.2019.09.005_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3181\/00379727-194-43086","article-title":"Hepatic catabolism of serum amyloid A during an acute phase response and chronic inflammation","volume":"194","author":"Gollaher","year":"1990","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.resinv.2019.09.005_bib16","article-title":"La siero amiloide A: biologia ed applicazioni cliniche","volume":"4","author":"Pallotti AB","year":"2003","journal-title":"Riv Med Lab - JLM."},{"issue":"4","key":"10.1016\/j.resinv.2019.09.005_bib17","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/ard.43.4.586","article-title":"Serum amyloid A protein concentration in progressive systemic sclerosis (scleroderma)","volume":"43","author":"Brandwein","year":"1984","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.resinv.2019.09.005_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110820","article-title":"Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis","volume":"10","author":"Lakota","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.resinv.2019.09.005_bib19","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1177\/0300060518760955","article-title":"High acute phase protein levels correlate with pulmonary and skin involvement in patients with diffuse systemic sclerosis","volume":"46","author":"Lis-Swiety","year":"2018","journal-title":"J Int Med Res"},{"issue":"4","key":"10.1016\/j.resinv.2019.09.005_bib20","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.4049\/jimmunol.166.4.2801","article-title":"Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases","volume":"166","author":"Vallon","year":"2001","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.resinv.2019.09.005_bib21","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/art.20301","article-title":"Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis","volume":"50","author":"O'Hara","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl 31","key":"10.1016\/j.resinv.2019.09.005_bib22","first-page":"S158","article-title":"Disease-modifying anti-rheumatic drug therapy and structural damage in early rheumatoid arthritis","volume":"21","author":"Mullan","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.resinv.2019.09.005_bib23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.mayocp.2018.05.026","article-title":"COPD guidelines: a review of the 2018 GOLD report","volume":"93","author":"Mirza","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.resinv.2019.09.005_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1164\/rccm.200705-678OC","article-title":"Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease","volume":"177","author":"Bozinovski","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.resinv.2019.09.005_bib25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1073\/pnas.1109382109","article-title":"Serum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease","volume":"109","author":"Bozinovski","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.resinv.2019.09.005_bib26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/01.CIR.0000089091.09527.B8","article-title":"Serum amyloid a in obstructive sleep apnea","volume":"108","author":"Svatikova","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.resinv.2019.09.005_bib27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1164\/rccm.201304-0726ST","article-title":"An official American Thoracic Society Clinical Practice Guideline: sleep apnea, sleepiness, and driving risk in noncommercial drivers. An update of a 1994 Statement","volume":"187","author":"Strohl","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.resinv.2019.09.005_bib28","first-page":"1599","article-title":"(Clinical implications of serum amyloid A level in patients with obstructive sleep apnea)","volume":"29","author":"Chen","year":"2009","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"5","key":"10.1016\/j.resinv.2019.09.005_bib29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.rmed.2010.12.010","article-title":"Analysis of serum amyloid A in sarcoidosis patients","volume":"105","author":"Bargagli","year":"2011","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.resinv.2019.09.005_bib30","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1378\/chest.09-1975","article-title":"Comparative evaluation of serum markers in pulmonary sarcoidosis","volume":"137","author":"Miyoshi","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.resinv.2019.09.005_bib31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2","volume":"181","author":"Chen","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.resinv.2019.09.005_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12016-015-8481-z","article-title":"Etiologies of sarcoidosis","volume":"49","author":"Chen","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"10.1016\/j.resinv.2019.09.005_bib33","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1046\/j.1365-2362.2001.00913.x","article-title":"Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders","volume":"31","author":"Salazar","year":"2001","journal-title":"Eur J Clin Investig"},{"issue":"10","key":"10.1016\/j.resinv.2019.09.005_bib34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/14789450.2018.1528148","article-title":"Sarcoidosis: proteomics and new perspectives for improving personalized medicine","volume":"15","author":"Landi","year":"2018","journal-title":"Expert Rev Proteomics"},{"issue":"6","key":"10.1016\/j.resinv.2019.09.005_bib35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaip.2014.09.007","article-title":"Developing and emerging clinical asthma phenotypes","volume":"2","author":"Hekking","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.resinv.2019.09.005_bib36","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.4049\/jimmunol.177.6.4072","article-title":"Serum amyloid A is an endogenous ligand that differentially induces IL-12 and IL-23","volume":"177","author":"He","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.resinv.2019.09.005_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4049\/jimmunol.181.1.22","article-title":"Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A","volume":"181","author":"Cheng","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.resinv.2019.09.005_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4049\/jimmunol.1100500","article-title":"Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice","volume":"187","author":"Ather","year":"2011","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.resinv.2019.09.005_bib39","first-page":"335","article-title":"The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer","volume":"34","author":"Zhang","year":"2015","journal-title":"Chin J Canc"},{"issue":"3","key":"10.1016\/j.resinv.2019.09.005_bib40","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/pr101154j","article-title":"Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer","volume":"10","author":"Sung","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.resinv.2019.09.005_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12935-019-0783-4","article-title":"The prognostic value of serum amyloid A in solid tumors: a meta-analysis","volume":"19","author":"Lin","year":"2019","journal-title":"Cancer Cell Int"},{"issue":"1115","key":"10.1016\/j.resinv.2019.09.005_bib42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/postgradmedj-2018-136004","article-title":"Association between serum amyloid A levels and cancers: a systematic review and meta-analysis","volume":"94","author":"Zhou","year":"2018","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.resinv.2019.09.005_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00018-008-8321-x","article-title":"Serum amyloid A: an acute-phase protein involved in tumour pathogenesis","volume":"66","author":"Malle","year":"2009","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"10.1016\/j.resinv.2019.09.005_bib44","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/sj.bjc.6605700","article-title":"Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis","volume":"102","author":"Cho","year":"2010","journal-title":"Br J Canc"},{"issue":"2","key":"10.1016\/j.resinv.2019.09.005_bib45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3892\/or.2012.2123","article-title":"Progression of non-small cell lung cancer: diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A","volume":"29","author":"Kanoh","year":"2013","journal-title":"Oncol Rep"},{"issue":"5","key":"10.1016\/j.resinv.2019.09.005_bib46","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.resinv.2019.03.010","article-title":"Serum amyloid A in patients with idiopathic pulmonary fibrosis","volume":"57","author":"Vietri","year":"2019","journal-title":"Respir Investig"},{"issue":"3","key":"10.1016\/j.resinv.2019.09.005_bib47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/thx.39.3.196","article-title":"Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis","volume":"39","author":"de Beer","year":"1984","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.resinv.2019.09.005_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176660","article-title":"A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis","volume":"12","author":"Ferrian","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.resinv.2019.09.005_bib49","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1128\/JCM.00467-17","article-title":"Discovery and validation of a six-marker serum protein signature for the diagnosis of active pulmonary tuberculosis","volume":"55","author":"De Groote","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.resinv.2019.09.005_bib50","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ijrobp.2012.06.018","article-title":"Serum amyloid a as a predictive marker for radiation pneumonitis in lung cancer patients","volume":"85","author":"Wang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.resinv.2019.09.005_bib51","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jcf.2016.10.009","article-title":"Biomarkers for cystic fibrosis drug development","volume":"15","author":"Muhlebach","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2019.09.005_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.acc.2019.01.002","article-title":"Acute phase reactant serum amyloid A in inflammation and other diseases","volume":"90","author":"Zhang","year":"2019","journal-title":"Adv Clin Chem"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534519301650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534519301650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:29:30Z","timestamp":1761949770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534519301650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2212534519301650"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2019.09.005","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum amyloid A: A potential biomarker of lung disorders","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2019.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}